M1 muscarinic acetylcholine receptor — Drug Target
All drugs that target M1 muscarinic acetylcholine receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Muscarinic M1 receptor agonist · Muscarinic M1 receptor partial agonist
Phase 3 pipeline (2)
- ACP-204 · ACADIA Pharmaceuticals Inc. · Muscarinic M1 receptor agonist · Psychiatry / Neurology
ACP-204 is a muscarinic M1 receptor agonist that enhances cholinergic neurotransmission to improve cognitive and psychiatric symptoms. - ALKS 2680 Dose 1 · Alkermes, Inc. · Muscarinic M1 receptor partial agonist · Psychiatry/Neurology
ALKS 2680 is a muscarinic M1 receptor partial agonist designed to enhance cognitive function and treat psychiatric symptoms.